Genfit Stock Quote GNFT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.03

Bid

4.025

Ask

4.05

Volume

277,294

3.98 Day's Range 4.21

2.84 52 Week Range 5.79

Market Cap

200.835M

Previous Close

4.065

Open

4.065

Last Trade

830

4.03

Last Trade Time

10:14:16

Financial Volume

VWAP

Average Volume (3m)

380,800

Shares Outstanding

49,834,983

Dividend Yield

PE Ratio

-6.92

Earnings Per Share (EPS)

-0.58

Revenue

38.68M

Net Profit

-28.89M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.genfit.com

Headquarters

Loos, Nord, Fra

Founded

1970

Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 4.07 €. Over the last year, Genfit shares have traded in a share price range of 2.84 € to 5.79 €.

Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 202.58 € million. Genfit has a price to earnings ratio (PE ratio) of -6.92.

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive Lille (France), Cambridge (Massachusetts...

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) July 9, 2024 – GENFIT (Nasdaq and...

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 9 juillet 2024 –...

GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque

GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque Lille (France...

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine Iqirvo® (élafibranor) 80 mg comprimés...

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis Ipsen’s Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.16	-3.81861575179	4.19	4.21	3.915	177131	4.02552546	DE
4	0.33	8.91891891892	3.7	4.24	3.47	221301	3.96037023	DE
12	0.815	25.3499222395	3.215	5.79	3.215	380800	4.383686	DE
26	0.31	8.33333333333	3.72	5.79	3.025	245812	4.13122358	DE
52	0.535	15.3075822604	3.495	5.79	2.84	250056	3.74277513	DE
156	0.704	21.1665664462	3.326	5.79	2.746	196845	3.78782879	DE
260	-11.97	-74.8125	16	20.96	2.746	307734	6.16935398	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 7.1126 (116.19%)	27.68M
RGCRegencell Bioscience Holdings Ltd	$ 17.0258 (86.89%)	1.06M
BFIBurgerFi International Inc	$ 0.38 (78.32%)	51.96M
SGMOSangamo Therapeutics Inc	$ 0.996 (48.21%)	57.35M
CREVCarbon Revolution Public Ltd	$ 9.1087 (47.63%)	6M
TANHTantech Holdings Ltd	$ 0.2455 (-49.89%)	3.52M
NMHINatures Miracle Holding Inc	$ 0.2044 (-47.83%)	4.33M
DXCMDexCom Inc	$ 64.72 (-39.99%)	16.98M
POAIPredictive Oncology Inc	$ 1.3198 (-29.42%)	3.55M
PMNProMIS Neurosciences Inc	$ 1.49 (-26.15%)	5.76M
SLNASelina Hospitality PLC	$ 0.04395 (16.89%)	166.66M
NVDANVIDIA Corporation	$ 113.885 (1.43%)	70.2M
SGMOSangamo Therapeutics Inc	$ 0.996 (48.21%)	57.35M
VWEVintage Wine Estates Inc	$ 0.0836 (19.60%)	53.67M
BFIBurgerFi International Inc	$ 0.38 (78.32%)	51.96M